Capstone Triton Financial Group, LLC Abb Vie Inc. Transaction History
Capstone Triton Financial Group, LLC
- $139 Million
- Q1 2024
A detailed history of Capstone Triton Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capstone Triton Financial Group, LLC holds 8,139 shares of ABBV stock, worth $1.4 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
8,139
Previous 7,987
1.9%
Holding current value
$1.4 Million
Previous $1.24 Million
19.81%
% of portfolio
1.06%
Previous 0.91%
Shares
14 transactions
Others Institutions Holding ABBV
# of Institutions
3,651Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.6M-
Vanguard Group Inc Valley Forge, PA170MShares$29.2 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$24.5 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13.4 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.79 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.25 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $303B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...